Skip to main content
Erschienen in:

Open Access 01.12.2025 | Research

The effectiveness of dyadic interventions for health outcomes of prostate cancer patients and informal caregivers: a systematic review and meta-analysis

verfasst von: Yuan Xiao, Jiao Sun, Min Liu, Haifeng Wang, Jingjing Guan

Erschienen in: BMC Nursing | Ausgabe 1/2025

Abstract

Background

Prostate cancer is a worldwide health issue, and current prostate cancer care extends to the patient‒caregiver dyadic setting, where individuals are interdependent and interact with each other as well as possible negative psychological and behavioural outcomes. However, the impact of dyadic care interventions on health outcome indicators for prostate cancer patients and their informal caregivers has yet to be examined.

Aim

To describe the characteristics of dyadic interventions involving patients with prostate cancer and their informal caregivers and investigate their effects on psychosocial health, sexual health, and dyadic relationships.

Methods

Ten electronic databases (Web of Science, Cochrane Library, PsycINFO, PubMed, Embase, CINAHL, CNKI, Wanfang, VIP, and SinoMed) were thoroughly searched for related publications published between the database’s founding and April 2024. The risk of bias for the included studies was evaluated using the Cochrane risk-of-bias tool, and a meta-analysis was performed using RevMan 5.4.

Results

This study identified and evaluated 19 RCTs reporting 22 different interventions, as well as outcome indicators for the three aspects of psychosocial health, sexual health, and dyadic relationships in prostate cancer patients and informal caregivers. A meta-analysis of pooled data revealed that for prostate cancer patients, the intervention improved dyadic coping (SMD95% CI [95% CI] = 0.22 [0.01;0.42], p = 0.04), and for informal caregivers the dyadic care intervention reduced anxiety (SMD95% CI [95% CI] = -0.35 [-0.65;-0.06], p = 0.02), enhanced self-efficacy (SMD [95% CI] = 0.22 [0.01;0.43], p = 0.04), and improved sexual functioning (SMD [95% CI] = 0.29 [0.05;0.54], p = 0.02). No statistically significant overall effects were observed for the other outcome indicators.

Conclusion

The results of this review indicate that dyadic care interventions benefit prostate cancer patients and informal caregivers. However, given features such as research quality and sample size, further randomized controlled trials with excellent study designs are needed in the future to evaluate and validate the efficacy of dyadic care treatments for patients with prostate cancer.

Trial registration

The protocol for this study is registered in PROSPERO with registration number (CRD42024567542).
Begleitmaterial
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12912-025-02769-8 .
Yuan Xiao and Jiao Sun made equal contributions to this manuscript.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Prostate cancer represents a significant public health challenge and is a leading contributor to illness and death among men across the globe; it ranks as the second most prevalent cancer in men, with approximately 1,414,000 new cases and 375,304 deaths recorded globally in 2020 [1]. Earlier diagnoses, increased treatment outcomes, and longer life expectancies, coupled with the greater prevalence of prostate cancer in older men, mean that the proportion of men being diagnosed and treated for prostate cancer will continue to rise in the foreseeable future. This trend has concerning consequences for patients’ overall well-being, including a heightened risk of metabolic disease and diminished quality of life [2, 3], many of which are linked to the treatments received. Throughout the illness, starting with the diagnostic assessment, patients commonly cope with cancer in the company of at least one caregiver while dealing with visits and appointments, side effects of treatment, changes in daily routines, and enduring considerable distress, all of which increase the need for caregivers.
Informal caregivers, who include friends and family members, are usually the main sources of care for men suffering from prostate cancer. Informal caregivers are individuals who have some relationship with the person being cared for; they are primarily responsible for providing care, emotional support, and financial support; they can be relatives, friends, partners, or neighbours, and they are usually neither trained in professional knowledge nor paid [4, 5]. Informal caregivers help alleviate health care system demands and contribute positively to patients’ adjustment to illness. However, caregiving behaviours can negatively influence caregivers’fitness, affecting their mental and physical wellness, health-associated quality of life (QOL), and relationship satisfaction. There is strong evidence that caregivers of people with prostate cancer have poorer mental health than the average person, with greater percentages of anxiety and depression diagnoses and high levels of caregiving stress [6]. In addition, caregivers have reported several ongoing physical challenges: problems with sleep, exhaustion, discomfort, absence of muscle strength, decreased desire for food, and weight gain [7]. Conversely, caregivers’problems are closely linked with patients’well-being, so early interventions that focus on how prostate cancer patients and informal caregivers cope with symptoms and consequences of the disease are critical.
In the past few decades, several types of interventions have been developed that target multiple outcome indicators. However, most interventional studies have tended to be limited to prostate cancer patients or their caregivers. For example, numerous studies have indicated that various psychosocial interventions for prostate cancer patients may alleviate feelings of depression or anxiety [8, 9] and increase their quality of life [10]. However, because cancer, as a codependent system, affects both patients and their caregivers and can lead to various physical and mental disorders during the course of the illness, the main concern related to cancer treatment and research has changed from a focus on one person to the patient–caregiver dyad [11]. Many approaches have been developed to assist patients and caregivers dealing with cancer as dyads.
In recent years, several systematic reviews of dyadic interventions for cancer patients have been published; however, these reviews included all cancer types and lacked cancer population specificity. In addition, Chen et al. [12] and Shen et al. [13] conducted systematic reviews and meta-analyses, respectively, and examined the results as they relate to the standard of life or emotional wellness of prostate cancer patient–spouse dyads. However, prostate cancer is often regarded as a “relational cancer”, a type of disease in which caregiver engagement may be required for certain therapeutic options that generally involve the areas of intimacy and procreation. Moreover, many physical and psychological challenges, such as urinary and bowel incontinence, sexual dysfunction, fatigue, and psychological distress, pose a threat to couples’ relationships and intimate experiences [14, 15]. Lyons and Lee’s dyadic illness management theory [16] states that a dyad’s health practices and outcomes are mutually reliant.

The review

Aim

To provide current evidence for successful approaches to dyadic care interventions, this study aimed to (1) describe the characteristics of various interventions and (2) investigate the impact of interventions on psychosocial health, sexual health, and relationships with dyads of people with prostate cancer and their caregivers.

Methods

Design

This systematic review and meta-analysis were reported as per the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines to ensure a transparent and comprehensive report of the review, and the study protocol has been registered in PROSPERO (registration number CRD42024567542).

Search strategy

Ten electronic databases (Web of Science, Cochrane Library, PsycINFO, PubMed, Embase, CINAHL, CNKI, Wanfang, VIP, and SinoMed) were thoroughly searched for related publications published between the database’s founding and April 2024. The following keywords and MeSH subject headings were applied: (prostatic neoplasms OR prostate neoplasms) AND (caregivers OR spouse OR wife) AND (intervention OR therapy OR exercise) AND (randomized controlled trial). Table S1 in the Additional file 1 contains specific information on the search approach. We also manually reviewed relevant reviews and reference lists to find and obtain other papers.

Selection criteria

Inclusion criteria

The inclusion criteria were as follows: (1) Study population: (a) patients with a confirmed diagnosis of prostate cancer and ≥ 18 years of age. (b) caregivers: informal caregivers; ≥18 years old. (2) Interventions: included interventions based on patients with prostate cancer and their informal caregivers. (3) Controls: any control group. (4) Outcome metrics: included health outcomes for prostate cancer patients and caregivers informally. (5) Study type: randomized controlled trial. (6) Language: Chinese or English were used in the published version of the study.

Exclusion criteria

The exclusion criteria were as follows: (1) conference abstracts, reviews, theses, study protocols, and duplicate reports, and (2) studies that did not have relevant data.

Study selection and data extraction

Two reviewers independently scrutinized the collected articles’ titles and abstracts for relevance and then compared the screening results to reach a consensus. The two reviewers independently reviewed the full texts of potentially relevant articles according to the selection criteria, and the selection was made by a consensus. Any remaining issues related to publication selection were settled by a third reviewer.
One reviewer gathered data from the listed studies and combined them into a Microsoft Excel file. Another reviewer independently verified the accuracy of the extracted data. The following data were extracted from the included studies: (1) study information, such as first author, year of publication, and country; (2) characteristics of patients and caregivers with prostate cancer (sample size and mean age); (3) interventions (process of the intervention, provider, content, duration, and frequency) and control measures; and (4) outcome metrics (duration of follow-up).

Quality assessment

The risk of bias for the included studies was evaluated via the Cochrane risk-of-bias tool [17] recommended by the Cochrane Collaboration. Information was retrieved from the articles regarding random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other sources of bias. Disagreements were settled by discussion or consultation with a third author.

Data analysis

A meta-analysis was performed using RevMan 5.4. The standardized mean difference (SMD) was calculated for the outcome indicators using different measurement tools, and the 95% CI was calculated for each effect size. Pooling of data from individual RCTs was conducted to obtain overall effects estimates and 95% CIs with the random-effects model (I2 > 50%) or fixed-effects model (I2 ≤ 50%) [18], and P < 0.05 was considered statistically significant. In addition, this analysis revealed publication bias via funnel plots [19], and a subgroup analysis was carried out from two perspectives, namely, duration (< 3 months, ≥ 3 months) and delivery method (offline, e-health, or mixed methods). A sensitivity analysis was conducted using the “remove one study”approach to evaluate the influence of each study on the overall effect size [20].

Results

Search results

A total of 7321 records were generated from the 7317 records searched in the database plus the 4 records manually searched. Of these, 2014 remained after the deletion of duplicates, of which 5128 were excluded after screening the titles and abstracts. After the full texts of the remaining 169 records were reviewed, a total of 19 randomized controlled trials were ultimately included in this study (Fig. 1).

Characteristics of the included studies

Between 2004 and 2022, 19 studies were published, most of which originated in the USA (n = 8), followed by the UK (n = 3) and China (n = 3), with fewer studies originating from other countries. Table S2 in Additional file 1 presents the specifics of each study.

Participants

The total sample size for the study comprised 17 [21] to 263 [22]pairs, and the patients’ and caregivers’ mean ages ranged from 51.7 to 77.0 years and 50.7 to 75.6 years, respectively. Two of the 19 studies did not report demographic information [21, 23]. In addition, of the relationships between patients and caregivers, 14 studies reported spousal or cohabiting relationships [21, 22, 2435], and 3 reported relationships limited to legal heterosexual couples [3638].

Interventions

Nineteen studies involved twenty-two varied interventions. Nurses delivered the majority of interventions (n = 8) [22, 25, 26, 3539], and in three of these interventions the care providers also involved sports coaches, counsellors [39], doctors [36] or researchers, psychotherapists, and nurse practitioners [37]. The interventions in two studies required participants to complete the intervention on their own by logging on to a specific website provided by the researcher [33, 34].
The included studies described multiple modes of intervention delivery. In ten studies, interventions were delivered via conference or course [2124, 27, 2932, 39], with 2 studies also involving the provision of information materials, a holistic needs assessment, and a personalized self-management care plan [39] or reading of a brochure. In 6 studies [25, 26, 28, 3537], the intervention was delivered in the form of counselling, with 2 studies also involving the mailing of an information brochure or the delivery of a multimedia film [26] via an app or in conjunction with Pelvic Floor Muscle Training (PFMT) [28]; in the other studies (n = 3), the intervention was delivered by having participants log on to a specific website, such as TrueNTH [33], TEMPO [34] or ESCP [38], on their own.

Control group

All participants but 1 in the control group used Survivorship Care Plans (SCP) [38]. The remaining 18 studies used standard care or usual care.

Outcome measures

Each study measured at least one outcome, including psychosocial health, sexual health, or an outcome related to dyadic relationships. For prostate cancer patients, the following ten outcomes were included in this study: psychosocial health (quality of life, neuropsychiatric symptoms, anxiety, depression, stress, self-efficacy), sexual health (sexual function, sexuality-related mental health), and dyadic relationships (relationship satisfaction, dyadic coping). For caregivers, the following nine outcomes were included: psychosocial health (quality of life, neuropsychiatric symptoms, anxiety, depression, stress, self-efficacy), sexual health (sexual function), and dyadic relationships (relationship satisfaction, dyadic coping). Other outcomes were not included in further analyses because they were reported in fewer than three studies.

Study quality

Among the 19 studies, 1 (5.2%) [26]had a low risk of bias; 5 (26.3%) [25, 27, 28, 32, 37] were judged to be have a high risk, mainly because they did not report on or blind participants and personnel; and the remaining 13 (68.4%) [2124, 2931, 3336, 38, 39] had “some concerns”. For the other three domains (random sequence generation, allocation concealment, and blinding of outcome assessment), 5–12 of the 19 studies were rated as having “some concerns”. Thirteen studies [23, 2534, 36, 39] were rated as having “low” risk because of the provision of sufficient evidence on the randomization process. In terms of allocation concealment, 7 studies [21, 2528, 31, 38] were assessed as “low” risk because of sufficient details of the implementation of allocation concealment, such as the use of sequential numbering or sealed envelopes, and 9 studies [22, 26, 3234, 3639] were assessed as “low” risk due to blinding study outcomes. The results of the risk of bias for the included studies are shown in Figs. 2 and 3.

Effectiveness

Figures S1 and S2 show detailed measurement results for Additional file 1.

Psychosocial health

Quality of life

For the meta-analysis of quality of life in prostate cancer patients, pooled data from 10 studies were used [21, 22, 24, 28, 29, 32, 34, 36, 38, 39]. These studies were heterogeneous (p < 0.00001, I2 = 93%), and a subgroup analysis revealed that patients’ quality of life was not significantly affected by the duration of the intervention (< 3 months: SMD95% CI [95% CI] = 0.62 [-0.09;1.34], p = 0.09; ≥3 months: SMD95% CI [95% CI] =-0.15 [-0.56;0.25], p = 0.46) (Figure S1a-1) or the way it was delivered (offline: SMD95% CI [95% CI] = 0.08 [-0.17;0.33], p = 0.53; e-Health: SMD95% CI [95% CI] = 0.16 [-0.19;0.51], p = 0.37; mixed methods: SMD95% CI [95% CI] =-2.16[-4.63;0.32], p = 0.09) (Figure S1a-2).
For caregiver quality of life, 7 studies [21, 22, 24, 28, 32, 34, 38] reported that the intervention’s overall effect was not statistically significant (SMD [95% CI] = 0.11 [-0.08;0.30], p = 0.26) (Figure S2a).

Neuropsychiatric symptoms

The overall outcomes revealed that there was no meaningful change in the neuropsychiatric symptoms of patients (SMD95% CI [95% CI] = -0.09 [-0.44;0.25], p = 0.59) (Figure S1b) or caregivers (SMD95% CI [95% CI] = -0.86 [-2.23;0.50], p = 0.22) (Figure S2b). Furthermore, because all included studies had intervention durations of less than 3 months, subgroup analyses were not possible for both.

Anxiety

Five studies evaluated how an intervention affects patients’ anxiety [28, 31, 34, 36, 39]. However, the combined results (Figure S1c) demonstrated high heterogeneity (p < 0.00001, I2 = 87%) and no intervention impact (SMD95% CI [95% CI] = -0.41 [-1.18;0.36], p = 0.30).
The impact of the intervention on caregivers’ anxiety was examined in five investigations [24, 28, 31, 34, 36]. The combined results (Figure S2c) revealed that the overall effect was statistically significant for anxiety (SMD95% CI [95% CI] = -0.35 [-0.65;-0.06], p = 0.02). Subgroup analyses revealed that intervention durations of less than three months (SMD95% CI [95% CI] = -0.50 [-0.87;-0.14], p = 0.007) (Figure S2c-1) and forms of intervention delivered through mixed methods (SMD95% CI [95% CI] = -0.51 [-0.92;-0.10], p = 0.01) (Figure S2c-2) were effective in reducing caregiver anxiety.

Depression

Six studies reported depression scores from prostate cancer patients [28, 30, 31, 34, 36, 39], and six studies reported depression scores from caregivers [24, 28, 30, 31, 34, 36]. Neither meta-analysis demonstrated an effect of the intervention on depression (patients: SMD95% CI [95% CI] = -0.21 [-0.68;0.26], p = 0.38; caregivers: SMD95% CI [95% CI] = -0.22 [-0.54;0.10], p = 0.18) (Figure S1d) (Figure S2d), and it is crucial to acknowledge that these studies had substantial heterogeneity (patients: p < 0.00001, I2 = 84%; caregivers: p = 0.02, I2 = 60%).

Stress

Among the included studies, only 3 investigated the impact of interventions on patient stress [27, 29, 30] (Figure S1e). The change in both groups of participants was not statistically significant (SMD95% CI [95% CI] = -0.02 [-0.21;0.16], p = 0.80). Only 2 studies investigated the effect of the intervention on caregiver stress [27, 30], and the results revealed no effect of the intervention (SMD95% CI [95% CI] = -0.17 [-0.39;0.05], p = 0.14) (Figure S2e).

Self-efficacy

Seven studies reported self-efficacy scores provided by prostate cancer patients [21, 22, 24, 28, 34, 38, 39] (Figure S1f). In contrast to the control group, the dyadic interventions failed to enhance patient self-efficacy in the intervention group (SMD95% CI [95% CI] = 0.04 [-0.15;0.23], p = 0.67) (Figure S1f).
Five studies reported self-efficacy ratings from caregivers [21, 22, 28, 34, 38] (Figure S2f), with low heterogeneity between studies (P = 0.20, I2 = 33%); caregivers in the intervention group outperformed those in the control group with respect to improving self-efficacy, with a statistically significant difference (SMD95% CI [95% CI] = 0.22 [0.01; 0.43], p = 0.04) (Figure S2f). Notably, interventions that lasted less than three months were related to increased caregiver self-efficacy (SMD95% CI [95% CI] = 0.28 [0.03;0.52], p = 0.03) (Figure S2f-1).

Sexual health

Sexual function

The meta-analysis of sexual function in prostate cancer patients pooled data from 3 studies [25, 28, 33] and revealed no intervention effect (SMD95% CI [95% CI] = 0.06 [-0.17;0.30], p = 0.60) (Figure S1g).
However, the 2 RCTs [25, 33] that included sexual function as an outcome indicator had statistically significant effects only on caregivers (SMD95% CI [95% CI] = 0.29 [0.05;0.54], p = 0.02) (Figure S2g).
Only three of the included studies reported on sexuality-related mental health outcome indicators for patients [25, 28, 31] (Figure S1h). The intervention group’s total effect did not show any substantial benefit (SMD95% CI [95% CI] = -0.05 [-0.29;0.20], p = 0.71), and subgroup analyses could not be performed because the duration of the intervention was greater than 3 months in all three studies. No studies have reported on sexuality-related mental health outcomes for caregivers.

Dyadic relationships

Relationship satisfaction

Four included studies, involving six different interventions [25, 28, 30, 37], assessed the impact of interventions on relationship satisfaction in patients (Figure S1i), and the heterogeneity test revealed substantial heterogeneity among the studies (P < 0.0001, I2 = 82%). To explore the heterogeneity, a subgroup analysis by intervention was performed. The results indicated that an intervention in the form of offline delivery increased patients’ relationship satisfaction (offline: SMD95% CI [95% CI] = 1.14 [0.69; 1.59], p < 0.00001); however, neither the duration of the intervention (< 3 months: SMD95% CI [95% CI] = 0.36 [-0.32; 1.04], p = 0.30; ≥3 months: SMD95% CI [95% CI] =-0.21 [-0.47; 0.04], p = 0.10) (Figure S1i-1) nor the other two intervention forms had a significant effect on patient relationship satisfaction (e-Health: SMD95% CI [95% CI] =-0.19 [-0.46; 0.08], p = 0.16; mixed methods: SMD95% CI [95% CI] =-0.04 [-0.26; 0.19], p = 0.75) (Figure S1i-2).
Five studies investigated the effects of treatments on caregiver relationship satisfaction [25, 2830, 37] (Figure S2h). The combined results indicate heterogeneity among these studies (P = 0.003, I2 = 70%), and none of the effects of the intervention effects were substantial (SMD95% CI [95% CI] = 0.21 [-0.07;0.49], p = 0.15).

Dyadic coping

Four studies reported dyadic coping by prostate cancer patients and caregivers [22, 27, 34, 38]; for patients, the findings revealed a statistically significant effect (SMD95% CI [95% CI] = 0.22 [0.01;0.42], p = 0.04) (Figure S1j); however, the intervention did not affect caregivers (SMD95% CI [95% CI] = 0.13 [-0.09;0.34], p = 0.25) (Figure S2i).

Sensitivity analysis

The elimination approach was employed to eliminate each study separately. After excluding studies by Yuan et al. [36] and Luo et al. [37], the overall heterogeneity in the literature decreased significantly, e.g., with the I2 for patient quality of life decreasing from 93 to 0%, the I2 for patient satisfaction decreasing from 82 to 0%, and the I2 for caregiver depression decreasing from 60 to 20%, which may be the relevant source of heterogeneity. For the remaining outcomes, the differences in the I2 values after the exclusion of any studies were usually minor, indicating that the meta-analysis results were generally reliable.

Publication bias

Given the few studies included (n < 10), only the quality-of-life outcome in patients with prostate cancer was evaluated for publication bias. The funnel plot shown in Figure S3 of the Additional file 1 indicates that the results showed that the distribution of the studies was generally symmetrical; therefore, the likelihood of publication bias in the included studies was low.

Discussion

This review identified and evaluated 19 RCTs reporting 22 different interventions by analysing the results of dyadic interventions for people with prostate cancer and their informal caregivers. These RCTs had been published over the past 20 years and included three outcome indicators for patients and caregivers. The majority of the investigations were rated as having a moderate probability of bias, and the findings of all meta-analyses revealed that the overall effect on prostate cancer patients was not related to the intervention on any of the included outcomes except for dyadic coping. In contrast, the intervention was effective on three outcome indicators: caregiver anxiety, self-efficacy, and sexual function. According to the subgroup analyses, caregivers’ anxiety improved, and self-efficacy increased, when the duration of the dyadic intervention was less than 3 months. Subgroup analyses indicated that interventions delivered in an offline format improved patients’ relationship satisfaction; however, when the duration of the dyadic intervention was less than 3 months, caregiver anxiety improved, self-efficacy increased, and mixed forms of dyadic interventions also contributed to reductions in caregiver anxiety. The heterogeneity among the studies in our systematic review may be attributed to several factors. First, variations in study design and methodology, including differences in randomization procedures, blinding, and interventional contents, may account for the observed variability. Second, it is vital to emphasize that the two studies that produced greater heterogeneity were both conducted in developing countries [36, 37] and that the data were more susceptible to variables such as the study’s context of exposure, the region of the included subjects, etc. Compared with other studies that were conducted in countries with large economies, such as the US and the UK, the findings from this study provide evidence to support the impact of the use of dyadic (patient–caregiver) interventions on differential health outcomes for prostate cancer patients as well as caregivers.

Summary of intervention effectiveness

Psychosocial health

A meta-analysis of studies of prostate cancer patients and their informal caregivers revealed no significant effect of dyadic care interventions on health-related quality of life, and the results of this study are consistent with those of previous studies [12]. Many factors contribute to quality of life, including mental, physical, social, and cognitive functioning [40]. On the one hand, the lack of effect of an intervention may be explained by several factors. First, the quality of life of the subjects included in some of the studies had already been assessed in a manner similar to that of the normal population at baseline, so the effect of the intervention was limited [21, 22]. Second, the content of the intervention implemented in the intervention group was broadly similar to that implemented in the control group; e.g., in Song et al.’s study [38] the NCI website used in the control group was similar to that used in the experimental group with the PERC mobile health care app, which had similar information, online chat and support features. In addition, even when standard care was set as the intervention in the control group, some force majeure issues, such as social support and economic levels, had an impact on quality of life [41]. On the other hand, according to some of the intervention studies, several potentially effective intervention mechanisms exist. First, the interventions mostly involved the prior organization of a multidisciplinary team, starting from the existing patient and caregiver problems and explaining the disease and its care to improve their comprehension so that effective measures can be applied to solve the actual problems [42]. Second, intervention processes are often long and monotonous, and including the caregiver in the care plan allows the prostate cancer dyad to empathize with one another and support each other’s coping, improving adherence to the intervention and quality of life [42]. Third, the intervention builds a relaxing atmosphere through empathy, communication, assistance, and attention from health care professionals to patients and caregivers, showing concern and professionalism and improving the dyad’s mental health as well as both patients’ and caregivers’ quality of life. Therefore, future dyadic interventions should incorporate these points to increase the quality of life for men with prostate cancer and their caregivers.
Depression and anxiety are prevalent in men with prostate cancer and lead to a lower quality of life, decreased treatment adherence, and increased mortality. Their caregivers are often more distressed than the patients are, and exhibit rates of major depression. The prevalence of generalized anxiety disorders may be up to twice as high as that in the general population and may remain elevated long after treatment [4346]. In line with previous findings [13], the intervention had no significant effect on depression in prostate cancer patients or caregivers. In contrast, this study revealed that the dyadic intervention significantly improved anxiety in caregivers, whereas no effective improvement in patient anxiety was observed; this is not surprising because patients and caregivers have different support needs. As the primary providers of care activities, caregivers carry a variety of physical, psychological, and financial burdens and face social pressures as well, with subgroup analyses revealing that an intervention duration of < 3 months significantly reduces their anxiety. However, this intervention effect was not sustained, with previous research suggesting that caregivers have more distress than patients do but receive less support [47]. Furthermore, the intervention provided them with information and support that reduced their negative appraisals of caregiving, uncertainty, and feelings of hopelessness and helped them learn how to cope with stress and symptom management. However, because prostate cancer is a ‘relational cancer’, many of the symptoms and sequelae of the disease affect both patients and their carers. In addition, because conventional cancer care or services do not provide sufficient social and family support during subsequent long-term care, the effectiveness of the interventions also change over time. Mixed-method interventions allow caregivers to feel less anxious. Offline interventions, such as conferencing, face-to-face communication, and coaching, are able to foster a more sympathetic connection and identify caretakers’ deeper needs [48, 49]. E-health interventions, in the form of audiovisuals, which take advantage of the internet’s portability and expandability, are capable of laying down information barriers between doctors and patients. A mixed-methods intervention that incorporates both approaches provides for more tailored and comprehensive assistance. Overall, given the aforementioned factors, intervenors should select acceptable formats for delivery methods for informal caregivers based on their characteristics and the circumstances of the scenario. The impact of implementing therapies focused on improving anxiety and depression in patients and their informal caregivers requires further investigation.
Self-efficacy has a powerful influence on a person’s motivation, perseverance, and thought processes and plays an important role in deciding whether to take action, the amount of work to put in, and how often to persevere when faced with obstacles or failures [50]. However, meta-analyses have shown that dyadic interventions do not have a significant impact on self-efficacy in prostate cancer patients. First, the included studies originated in developed countries, where the study population was well educated and well adjusted, making it harder to achieve the desired intervention outcomes. Second, most studies did not include self-efficacy as a primary outcome and therefore did not design targeted intervention modules to improve it. Conversely, the dyadic intervention improved caregivers’ self-efficacy through mechanisms comparable to those that promote other psychosocial outcomes. Future research should focus on study participants who require support and help or add routine care to assess self-efficacy.

Sexual health

As a component of overall health, the World Health Organization defines sexual health as the state of physical, emotional, spiritual, and social well-being related to sexuality [51]. All aspects of sexual health are affected after prostate cancer treatment. Furthermore, most caregivers are postmenopausal women whose sexual function also requires assistance. Sexual dysfunction is one of the most prevalent sexual health issues, and it encompasses not only erectile dysfunction but also impaired arousal and orgasm, with far-reaching consequences for intimacy, communication, and fulfilment in relationships between patients and companions [52]. This meta-analysis revealed three research reports on the consequences of dyadic therapies for patients’ sexual function [25, 28, 33], two of which involved caregivers [25, 33]. The findings did not show an effect of dyadic interventions on the patients but did show an effect on the caregivers. The reasons for this may be include that patients’ distress with penile shortening and erectile and urinary dysfunction limits their desire to engage in sexual activity during recovery, irrespective of the primary type of treatment. Most of the study intervention durations and follow-up times may be premature; previous studies have shown that the mean recovery time for patients whose sexual function returned to baseline levels was 13.2 months [53] and that some patients were not able to regain firmer and more reliable erectile function until 2–4 years after surgery. Given that suppressing emotions and thoughts is not only a coping mechanism but also a means of maintaining relationship continuity, patients and their caregivers often choose to avoid discussing topics related to sexual issues [54]. Interventions related to sexual function have gradually shifted from the early patient-dominant, caregiver-supportive model to one in which both are equal participants in the intervention [55]. The interventions included in the study not only provided pharmacological and surgical treatment for erectile dysfunction but also involved comprehensive psychological and sexual counselling, which has helped them recognize the need for communication, mutual acceptance, and assistance in sexual rehabilitation after prostate cancer care, in turn helping improve sexual function. Due to the limited number of meta-analyses, more high-quality randomized controlled trials could be conducted in the future for prostate cancer patients and their caregivers. The reliability and validity of the intervention results still must be interpreted in conjunction with newly published studies and follow-up work.

Dyadic relationships

Dyadic coping is a process in which both individuals and partners collaborate to maintain or reestablish the balance of mental health, physical health, and the dyadic relationship [56]. In this study, the results of the meta-analysis revealed that the intervention was effective in improving dyadic coping in patients. Communication and obtaining expert direction in interventions can help dyad members develop relationships and self-expression as well as understand each other’s genuine thoughts and emotions and provide encouragement and support. However, prostate cancer affects not only the individual but also the structure and hierarchy of the entire family. Some studies have reported a strong positive correlation between dyadic coping and relationship satisfaction [57], which is the most commonly studied dependent variable in dyadic intervention studies. Given that female caregivers receive less attention and appear to be at greater risk of reduced marital satisfaction than men, reduced marital satisfaction may be of greater concern to prostate cancer patient‒caregiver dyads [43]. Evidence among prostate cancer patients indicates that greater marital satisfaction is linked to patient health several years after treatment [58], as well as with a longer median survival time [59], and that there is a connection between physical health, mental health, and partner relationship satisfaction in couples who have faced prostate cancer. Although meta-analyses have shown that interventions do not have a significant effect on relationship satisfaction, the theory of spousal disclosed intimacy suggests that enhanced dyadic communication has a positive effect on spousal intimacy, as reflected in the results of Luo et al.‘s [37] intervention, which are consistent with the results of a previous intervention on enhancing couple communication to increase relationship satisfaction [60]. Furthermore, the statistically significant findings of this subgroup analysis should be interpreted with caution, because only one trial took the intervention offline. As a result, future dyadic interventions should include caregivers, incorporating communication interventions to help them navigate potential mutual benefits and conducting more studies of higher-quality to provide more conclusive evidence, such as determining appropriate intervention durations and providing enrichment support resources.

Implications for practice and research

This review has important implications for the study of prostate cancer care. In clinical practice, our outcome study reinforces the importance of providing nursing interventions in the context of prostate cancer dyads. In contemporary cancer care in the hospital or at home, it is critical to change from focusing solely on individual interventions to providing full dyadic help that fosters mental and physical health and accomplishes holistic care and optimal recovery for both patients and informal caregivers. Health care professionals should be proactive in targeting both individual and dyadic factors to provide timely and personalized interventions to effectively benefit the prostate cancer dyad.
This study assesses the effectiveness of dyadic care interventions in the field of prostate cancer in improving outcomes related to psychosocial health, sexual health, and dyadic relationships for patients and their informal caregivers; it presents multiple proposals for additional studies in this area. First, caregivers must be included in care plans to better harness, and make numerous suggestions for, additional studies of the potential interplay between patients and their informal caregivers. Caregivers frequently are viewed as external observers or only as care providers. Health care professionals must be aware that caregivers can also be affected by cancer and should view them as coreceivers of care. Ideally, a structured and systematic care plan would help dyads better cope with the effects of cancer. Therefore, further research is needed on cost-effective and efficient care planning for prostate cancer patients and caregivers in busy health care settings. Second, future research on the use of measurement tools, such as assessments of quality of life, could consider the use of both disease-specific and more comprehensive measures of a healthy quality of life. More attention must be paid to other easily overlooked endpoints, such as loneliness, distress, and self-efficacy. Finally, the results of the meta-analysis revealed that the intervention did not have a significant effect on more than half of the outcome indicators; this illustrates, on the one hand, the complexity of dyadic care interventions in the field of prostate cancer and the need for additional studies using broad and high-quality samples to validate the efficacy of care interventions in improving the dyadic care of prostate cancer patients. On the other hand, the best features associated with successful dyadic care treatments found in this research can still be evaluated and employed in future approaches and research with a commitment to exploring the factors that contribute to their potential success.

Limitations

This review has several limitations. First, although as many studies as possible were included that met the criteria by snowballing through manual searches, we included only studies published in English and Chinese due to language restrictions imposed by the researchers, which may have resulted in missed articles written in other languages. In addition, some studies were excluded because they did not adequately report data and because the authors did not respond to our requests for clarification. Furthermore, the high degree of heterogeneity due to the diversity of studies in terms of country of origin, interventions (modality, frequency, duration), metrics, and time points of measurement, as well as the predominance of studies from high-income countries, may limit the applicability of findings to low- and middle-income countries, highlighting the necessity for further investigation in these contexts. Finally, although subgroup analyses identified intervention designs of varying durations, the small number of studies in every subgroup limits robust comparisons. Given the moderate to serious chance of bias in current studies, there is a need for high-quality evidence on prostate cancer care through rigorous study design.

Conclusions

This review analyses the effectiveness of dyadic care intervention studies of the psychosocial health, sexual health, and dyadic relationships of prostate cancer patients and their informal caregivers. A meta-analysis of three outcome indicators revealed that the dyadic care intervention was effective only for the outcome indicators of patients’ dyadic coping and caregivers’ anxiety, self-efficacy, and sexual function. Despite the limitations of the meta-analysis, it could still offer some insight. Researchers should prioritize methodological quality; provide comprehensive details on random sequence generation and blinded implementation; and perform large-scale, multicentre research. In addition, to examine and confirm the effectiveness of dyadic care interventions, future studies should design more comprehensive intervention programmes with appropriately longer follow-up periods and incorporate the specific needs of dyads.

Acknowledgements

The authors thank AJE for the language of the document.

Declarations

Not applicable.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by-nc-nd/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate Cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health. 2022;10:811044.PubMedPubMedCentralCrossRef Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate Cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health. 2022;10:811044.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Edmunds K, Tuffaha H, Galvão DA, Scuffham P, Newton RU. Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature review. Support Care Cancer. 2020;28(5):2079–93.PubMedCrossRef Edmunds K, Tuffaha H, Galvão DA, Scuffham P, Newton RU. Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature review. Support Care Cancer. 2020;28(5):2079–93.PubMedCrossRef
3.
Zurück zum Zitat Nguyen PL, Alibhai SMH, Basaria S, D’Amico AV, Kantoff PW, Keating NL, Penson DF, Rosario DJ, Tombal B, Smith MR. Adverse effects of Androgen Deprivation Therapy and Strategies to mitigate them. Eur Urol. 2015;67(5):825–36.PubMedCrossRef Nguyen PL, Alibhai SMH, Basaria S, D’Amico AV, Kantoff PW, Keating NL, Penson DF, Rosario DJ, Tombal B, Smith MR. Adverse effects of Androgen Deprivation Therapy and Strategies to mitigate them. Eur Urol. 2015;67(5):825–36.PubMedCrossRef
4.
Zurück zum Zitat Morrison V, Zarzycki M, Vilchinsky N, Sanderman R, Lamura G, Fisher O, Ferraris G, Elayan S, Buskens E, Bei E et al. A multinational longitudinal study incorporating intensive methods to Examine Caregiver experiences in the context of Chronic Health conditions: protocol of the ENTWINE-iCohort. Int J Environ Res Public Health. 2022;19(2). Morrison V, Zarzycki M, Vilchinsky N, Sanderman R, Lamura G, Fisher O, Ferraris G, Elayan S, Buskens E, Bei E et al. A multinational longitudinal study incorporating intensive methods to Examine Caregiver experiences in the context of Chronic Health conditions: protocol of the ENTWINE-iCohort. Int J Environ Res Public Health. 2022;19(2).
6.
Zurück zum Zitat Borji M, Nourmohammadi H, Otaghi M, Salimi AH, Tarjoman A. Positive effects of cognitive behavioral therapy on Depression, anxiety and stress of Family caregivers of patients with prostate Cancer: a Randomized Clinical Trial. Asian Pac J Cancer Prev. 2017;18(12):3207–12.PubMedPubMedCentral Borji M, Nourmohammadi H, Otaghi M, Salimi AH, Tarjoman A. Positive effects of cognitive behavioral therapy on Depression, anxiety and stress of Family caregivers of patients with prostate Cancer: a Randomized Clinical Trial. Asian Pac J Cancer Prev. 2017;18(12):3207–12.PubMedPubMedCentral
7.
Zurück zum Zitat Sun V, Grant M, Koczywas M, Freeman B, Zachariah F, Fujinami R, Ferraro CD, Uman G, Ferrell B. Effectiveness of an interdisciplinary palliative care intervention for family caregivers in lung cancer. Cancer. 2015;121(20):3737–45.PubMedCrossRef Sun V, Grant M, Koczywas M, Freeman B, Zachariah F, Fujinami R, Ferraro CD, Uman G, Ferrell B. Effectiveness of an interdisciplinary palliative care intervention for family caregivers in lung cancer. Cancer. 2015;121(20):3737–45.PubMedCrossRef
8.
Zurück zum Zitat Beard C, Stason WB, Wang Q, Manola J, Dean-Clower E, Dusek JA, DeCristofaro S, Webster A, Doherty-Gilman AM, Rosenthal DS, et al. Effects of complementary therapies on clinical outcomes in patients being treated with radiation therapy for prostate cancer. Cancer. 2011;117(1):96–102.PubMedCrossRef Beard C, Stason WB, Wang Q, Manola J, Dean-Clower E, Dusek JA, DeCristofaro S, Webster A, Doherty-Gilman AM, Rosenthal DS, et al. Effects of complementary therapies on clinical outcomes in patients being treated with radiation therapy for prostate cancer. Cancer. 2011;117(1):96–102.PubMedCrossRef
9.
Zurück zum Zitat Ilie G, Rendon R, Mason R, MacDonald C, Kucharczyk MJ, Patil N, Bowes D, Bailly G, Bell D, Lawen J, et al. A Comprehensive 6-mo prostate Cancer patient empowerment program decreases psychological distress among men undergoing curative prostate Cancer Treatment: a Randomized Clinical Trial. Eur Urol. 2023;83(6):561–70.PubMedCrossRef Ilie G, Rendon R, Mason R, MacDonald C, Kucharczyk MJ, Patil N, Bowes D, Bailly G, Bell D, Lawen J, et al. A Comprehensive 6-mo prostate Cancer patient empowerment program decreases psychological distress among men undergoing curative prostate Cancer Treatment: a Randomized Clinical Trial. Eur Urol. 2023;83(6):561–70.PubMedCrossRef
10.
Zurück zum Zitat Huang T, Su H, Zhang S, Huang Y. Reminiscence therapy-based care program serves as an optional nursing modality in alleviating anxiety and depression, improving quality of life in surgical prostate cancer patients. Int Urol Nephrol. 2022;54(10):2467–76.PubMedPubMedCentralCrossRef Huang T, Su H, Zhang S, Huang Y. Reminiscence therapy-based care program serves as an optional nursing modality in alleviating anxiety and depression, improving quality of life in surgical prostate cancer patients. Int Urol Nephrol. 2022;54(10):2467–76.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Fletcher BS, Miaskowski C, Given B, Schumacher K. The cancer family caregiving experience: an updated and expanded conceptual model. Eur J Oncol Nurs. 2012;16(4):387–98.PubMedCrossRef Fletcher BS, Miaskowski C, Given B, Schumacher K. The cancer family caregiving experience: an updated and expanded conceptual model. Eur J Oncol Nurs. 2012;16(4):387–98.PubMedCrossRef
12.
Zurück zum Zitat Chen W, Li H, Qin N, Zhou J, Ou-Yang J, Wang K-Y. Effectiveness of couple-based interventions for prostate cancer patients and their spouses on their quality of life: a systematic review and meta-analysis. Support Care Cancer. 2022;31(1). Chen W, Li H, Qin N, Zhou J, Ou-Yang J, Wang K-Y. Effectiveness of couple-based interventions for prostate cancer patients and their spouses on their quality of life: a systematic review and meta-analysis. Support Care Cancer. 2022;31(1).
13.
Zurück zum Zitat Shen B, Sun J, Yu Z, Xu G, Zhou Y. Are couple-based psychological interventions beneficial for the mental health of prostate cancer patients and their spouses? A systematic review and meta‐analysis. Clin Psychol Psychother. 2023;31(1). Shen B, Sun J, Yu Z, Xu G, Zhou Y. Are couple-based psychological interventions beneficial for the mental health of prostate cancer patients and their spouses? A systematic review and meta‐analysis. Clin Psychol Psychother. 2023;31(1).
14.
Zurück zum Zitat Wootten AC, Abbott JM, Osborne D, Austin DW, Klein B, Costello AJ, Murphy DG. The impact of prostate cancer on partners: a qualitative exploration. Psychooncology. 2014;23(11):1252–8.PubMedCrossRef Wootten AC, Abbott JM, Osborne D, Austin DW, Klein B, Costello AJ, Murphy DG. The impact of prostate cancer on partners: a qualitative exploration. Psychooncology. 2014;23(11):1252–8.PubMedCrossRef
15.
Zurück zum Zitat Harden J, Sanda MG, Wei JT, Yarandi HN, Hembroff L, Hardy J, Northouse L. Survivorship after prostate cancer treatment: spouses’ quality of life at 36 months. Oncol Nurs Forum. 2013;40(6):567–73.PubMedPubMedCentralCrossRef Harden J, Sanda MG, Wei JT, Yarandi HN, Hembroff L, Hardy J, Northouse L. Survivorship after prostate cancer treatment: spouses’ quality of life at 36 months. Oncol Nurs Forum. 2013;40(6):567–73.PubMedPubMedCentralCrossRef
16.
17.
Zurück zum Zitat Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.PubMedPubMedCentralCrossRef Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ-BRITISH Med J. 2003;327(7414):557–60.CrossRef Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ-BRITISH Med J. 2003;327(7414):557–60.CrossRef
19.
Zurück zum Zitat Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ-BRITISH Med J. 1997;315(7109):629–34.CrossRef Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ-BRITISH Med J. 1997;315(7109):629–34.CrossRef
20.
Zurück zum Zitat Iyengar S, Greenhouse J. Sensitivity analysis and diagnostics. In: Cooper H, Hedges LV, Valentine JC, editors. Handbook of research synthesis and meta-analysis. 2nd ed. New York: Russell Sage Foundation; 2009. p. 417-33. Iyengar S, Greenhouse J. Sensitivity analysis and diagnostics. In: Cooper H, Hedges LV, Valentine JC, editors. Handbook of research synthesis and meta-analysis. 2nd ed. New York: Russell Sage Foundation; 2009. p. 417-33.
21.
Zurück zum Zitat McCaughan E, Curran C, Northouse L, Parahoo K. Evaluating a psychosocial intervention for men with prostate cancer and their partners: outcomes and lessons learned from a randomized controlled trial. Appl Nurs Res. 2018;40:143–51.PubMedCrossRef McCaughan E, Curran C, Northouse L, Parahoo K. Evaluating a psychosocial intervention for men with prostate cancer and their partners: outcomes and lessons learned from a randomized controlled trial. Appl Nurs Res. 2018;40:143–51.PubMedCrossRef
22.
Zurück zum Zitat Northouse LL, Mood DW, Schafenacker A, Montie JE, Sandler HM, Forman JD, Hussain M, Pienta KJ, Smith DC, Kershaw T. Randomized clinical trial of a family intervention for prostate cancer patients and their spouses. Cancer. 2007;110(12):2809–18.PubMedCrossRef Northouse LL, Mood DW, Schafenacker A, Montie JE, Sandler HM, Forman JD, Hussain M, Pienta KJ, Smith DC, Kershaw T. Randomized clinical trial of a family intervention for prostate cancer patients and their spouses. Cancer. 2007;110(12):2809–18.PubMedCrossRef
23.
Zurück zum Zitat Walker LM, Hampton AJ, Wassersug RJ, Thomas BC, Robinson JW. Androgen Deprivation Therapy and maintenance of intimacy: a randomized controlled pilot study of an educational intervention for patients and their partners. Contemp Clin Trials. 2013;34(2):227–31.PubMedCrossRef Walker LM, Hampton AJ, Wassersug RJ, Thomas BC, Robinson JW. Androgen Deprivation Therapy and maintenance of intimacy: a randomized controlled pilot study of an educational intervention for patients and their partners. Contemp Clin Trials. 2013;34(2):227–31.PubMedCrossRef
24.
Zurück zum Zitat Campbell LC, Keefe FJ, Scipio C, McKee DC, Edwards CL, Herman SH, Johnson LE, Colvin OM, McBride CM, Donatucci C. Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners. Cancer. 2007;109(S2):414–24.PubMedCrossRef Campbell LC, Keefe FJ, Scipio C, McKee DC, Edwards CL, Herman SH, Johnson LE, Colvin OM, McBride CM, Donatucci C. Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners. Cancer. 2007;109(S2):414–24.PubMedCrossRef
25.
Zurück zum Zitat Chambers SK, Occhipinti S, Schover L, Nielsen L, Zajdlewicz L, Clutton S, Halford K, Gardiner RA, Dunn J. A randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer and their female partners. Psychooncology. 2015;24(7):748–56.PubMedCrossRef Chambers SK, Occhipinti S, Schover L, Nielsen L, Zajdlewicz L, Clutton S, Halford K, Gardiner RA, Dunn J. A randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer and their female partners. Psychooncology. 2015;24(7):748–56.PubMedCrossRef
26.
Zurück zum Zitat Chien C, Chung H, Liu K, Pang S, Wu C, Chang Y, Huang X, Chang Y, Lin T, Lin W, et al. Effectiveness of a couple-based psychosocial intervention on patients with prostate cancer and their partners: a quasi‐experimental study. J Adv Nurs (John Wiley sons inc). 2020;76(10):2572–85. Chien C, Chung H, Liu K, Pang S, Wu C, Chang Y, Huang X, Chang Y, Lin T, Lin W, et al. Effectiveness of a couple-based psychosocial intervention on patients with prostate cancer and their partners: a quasi‐experimental study. J Adv Nurs (John Wiley sons inc). 2020;76(10):2572–85.
27.
Zurück zum Zitat Couper J, Collins A, Bloch S, Street A, Duchesne G, Jones T, Olver J, Love A. Cognitive existential couple therapy in men and partners facing localised prostate cancer: a randomised controlled trial. BJU Int. 2015;115(Suppl 5):35–45.PubMedCrossRef Couper J, Collins A, Bloch S, Street A, Duchesne G, Jones T, Olver J, Love A. Cognitive existential couple therapy in men and partners facing localised prostate cancer: a randomised controlled trial. BJU Int. 2015;115(Suppl 5):35–45.PubMedCrossRef
28.
Zurück zum Zitat Karlsen RV, Bidstrup PE, Giraldi A, Hvarness H, Bagi P, Lauridsen SV, Albieri V, Frederiksen M, Krause E, Due U, et al. Couple counseling and pelvic floor muscle training for men operated for prostate Cancer and for their female partners: results from the Randomized ProCan Trial. Sex Med. 2021;9(3):100350.PubMedPubMedCentralCrossRef Karlsen RV, Bidstrup PE, Giraldi A, Hvarness H, Bagi P, Lauridsen SV, Albieri V, Frederiksen M, Krause E, Due U, et al. Couple counseling and pelvic floor muscle training for men operated for prostate Cancer and for their female partners: results from the Randomized ProCan Trial. Sex Med. 2021;9(3):100350.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Malcarne VL, Ko CM, Roesch SC, Banthia R, Sadler GR. Efficacy of problem-solving therapy for spouses of men with prostate cancer: a randomized controlled trial. Psycho-oncology. 2018;28(3):497–504.PubMedCrossRef Malcarne VL, Ko CM, Roesch SC, Banthia R, Sadler GR. Efficacy of problem-solving therapy for spouses of men with prostate cancer: a randomized controlled trial. Psycho-oncology. 2018;28(3):497–504.PubMedCrossRef
30.
Zurück zum Zitat Manne SL, Kashy DA, Zaider T, Kissane D, Lee D, Kim IY, Heckman CJ, Penedo FJ, Murphy E, Virtue SM. Couple-focused interventions for men with localized prostate cancer and their spouses: a randomized clinical trial. Br J Health Psychol. 2019;24(2):396–418.PubMedPubMedCentralCrossRef Manne SL, Kashy DA, Zaider T, Kissane D, Lee D, Kim IY, Heckman CJ, Penedo FJ, Murphy E, Virtue SM. Couple-focused interventions for men with localized prostate cancer and their spouses: a randomized clinical trial. Br J Health Psychol. 2019;24(2):396–418.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Robertson J, McNamee P, Molloy G, Hubbard G, McNeill A, Bollina P, Kelly D, Forbat L. Couple-based psychosexual support following prostate Cancer surgery: results of a feasibility pilot randomized Control Trial. J Sex Med. 2016;13(8):1233–42.PubMedCrossRef Robertson J, McNamee P, Molloy G, Hubbard G, McNeill A, Bollina P, Kelly D, Forbat L. Couple-based psychosexual support following prostate Cancer surgery: results of a feasibility pilot randomized Control Trial. J Sex Med. 2016;13(8):1233–42.PubMedCrossRef
32.
Zurück zum Zitat Winters-Stone KM, Lyons KS, Dobek J, Dieckmann NF, Bennett JA, Nail L, Beer TM. Benefits of partnered strength training for prostate cancer survivors and spouses: results from a randomized controlled trial of the exercising together project. J Cancer Surviv. 2016;10(4):633–44.PubMedCrossRef Winters-Stone KM, Lyons KS, Dobek J, Dieckmann NF, Bennett JA, Nail L, Beer TM. Benefits of partnered strength training for prostate cancer survivors and spouses: results from a randomized controlled trial of the exercising together project. J Cancer Surviv. 2016;10(4):633–44.PubMedCrossRef
33.
Zurück zum Zitat Wittmann D, Mehta A, Bober SL, Zhu Z, Daignault-Newton S, Dunn RL, Braun TM, Carter C, Duby A, Northouse LL, et al. TrueNTH sexual recovery intervention for couples coping with prostate cancer: randomized controlled trial results. Cancer. 2022;128(7):1513–22.PubMedCrossRef Wittmann D, Mehta A, Bober SL, Zhu Z, Daignault-Newton S, Dunn RL, Braun TM, Carter C, Duby A, Northouse LL, et al. TrueNTH sexual recovery intervention for couples coping with prostate cancer: randomized controlled trial results. Cancer. 2022;128(7):1513–22.PubMedCrossRef
34.
Zurück zum Zitat Lambert SD, Duncan LR, Culos-Reed SN, Hallward L, Higano CS, Loban E, Katz A, De Raad M, Ellis J, Korman MB, et al. Feasibility, acceptability, and clinical significance of a Dyadic, Web-Based, Psychosocial and Physical Activity Self-Management Program (< i > TEMPO) tailored to the needs of men with prostate Cancer and their caregivers: a Multi-center Randomized Pilot Trial. Curr Oncol. 2022;29(2):785–804.PubMedPubMedCentralCrossRef Lambert SD, Duncan LR, Culos-Reed SN, Hallward L, Higano CS, Loban E, Katz A, De Raad M, Ellis J, Korman MB, et al. Feasibility, acceptability, and clinical significance of a Dyadic, Web-Based, Psychosocial and Physical Activity Self-Management Program (< i > TEMPO) tailored to the needs of men with prostate Cancer and their caregivers: a Multi-center Randomized Pilot Trial. Curr Oncol. 2022;29(2):785–804.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Thornton AA, Perez MA, Meyerowitz BE. Patient and Partner Quality of Life and Psychosocial Adjustment following radical prostatectomy. J Clin Psychol Med Settings. 2004;11(1):15–30.CrossRef Thornton AA, Perez MA, Meyerowitz BE. Patient and Partner Quality of Life and Psychosocial Adjustment following radical prostatectomy. J Clin Psychol Med Settings. 2004;11(1):15–30.CrossRef
36.
Zurück zum Zitat Yuan H, Deng J, Chen Y, Liang Y, Chen Y, Shen S, Li S. Effect of dyadic coping intervention on emotion management and quality of life in elderly patients with prostate cancer and their spouses. Chin J Hum Sexuality. 2021;30(4):4. Yuan H, Deng J, Chen Y, Liang Y, Chen Y, Shen S, Li S. Effect of dyadic coping intervention on emotion management and quality of life in elderly patients with prostate cancer and their spouses. Chin J Hum Sexuality. 2021;30(4):4.
37.
Zurück zum Zitat Luo Z, Huang D, Yang J, Deng L, Liu T, Cao L. Effect of spouse-based self-disclosure intervention on psychological distress and intimate relationship in patients with prostate cancer during radiotherapy. Chin Nurs Manage. 2022;22(7):1020-5. Luo Z, Huang D, Yang J, Deng L, Liu T, Cao L. Effect of spouse-based self-disclosure intervention on psychological distress and intimate relationship in patients with prostate cancer during radiotherapy. Chin Nurs Manage. 2022;22(7):1020-5.
38.
Zurück zum Zitat Song L, Guo P, Tan X, Chen RC, Nielsen ME, Birken SA, Koontz BF, Northouse LL, Mayer DK. Enhancing survivorship care planning for patients with localized prostate cancer using a couple-focused web-based, mHealth program: the results of a pilot feasibility study. J Cancer Surviv. 2021;15(1):99–108.PubMedCrossRef Song L, Guo P, Tan X, Chen RC, Nielsen ME, Birken SA, Koontz BF, Northouse LL, Mayer DK. Enhancing survivorship care planning for patients with localized prostate cancer using a couple-focused web-based, mHealth program: the results of a pilot feasibility study. J Cancer Surviv. 2021;15(1):99–108.PubMedCrossRef
39.
Zurück zum Zitat Paterson C, Primeau C, Nabi G. A pilot randomised controlled trial of a multimodal supportive care (ThriverCare) intervention for managing unmet supportive care needs in men with metastatic prostate cancer on hormonal treatment and their partner/caregivers. Eur J Oncol Nurs. 2018;37:65–73.PubMedCrossRef Paterson C, Primeau C, Nabi G. A pilot randomised controlled trial of a multimodal supportive care (ThriverCare) intervention for managing unmet supportive care needs in men with metastatic prostate cancer on hormonal treatment and their partner/caregivers. Eur J Oncol Nurs. 2018;37:65–73.PubMedCrossRef
40.
Zurück zum Zitat Clayson DJ, Wild DJ, Quarterman P, Duprat-Lomon I, Kubin M, Coons SJ. A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials. PharmacoEconomics. 2006;24(8):751–65.PubMedCrossRef Clayson DJ, Wild DJ, Quarterman P, Duprat-Lomon I, Kubin M, Coons SJ. A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials. PharmacoEconomics. 2006;24(8):751–65.PubMedCrossRef
41.
Zurück zum Zitat Tang L, Qiang W, Wang Y, Zhang F, Jiao J, Shen A. Research status of influencing factors of quality of life of cancer patients [J]. J Nurs Educ. 2019;34(11):985–7. Tang L, Qiang W, Wang Y, Zhang F, Jiao J, Shen A. Research status of influencing factors of quality of life of cancer patients [J]. J Nurs Educ. 2019;34(11):985–7.
42.
Zurück zum Zitat Xu J, Zhu T, Gu Z, Lu T, Shi Y. The impact of intervention based on dyadic disease management theory on self-efficacy and quality of life in elderly patients with ischemic stroke. Jiangsu Health Syst Manage. 2024;35(04):532–5. Xu J, Zhu T, Gu Z, Lu T, Shi Y. The impact of intervention based on dyadic disease management theory on self-efficacy and quality of life in elderly patients with ischemic stroke. Jiangsu Health Syst Manage. 2024;35(04):532–5.
43.
Zurück zum Zitat Couper J, Bloch S, Love A, Macvean M, Duchesne GM, Kissane D. Psychosocial adjustment of female partners of men with prostate cancer: a review of the literature. Psychooncology. 2006;15(11):937–53.PubMedCrossRef Couper J, Bloch S, Love A, Macvean M, Duchesne GM, Kissane D. Psychosocial adjustment of female partners of men with prostate cancer: a review of the literature. Psychooncology. 2006;15(11):937–53.PubMedCrossRef
44.
Zurück zum Zitat Hyde MK, Legg M, Occhipinti S, Lepore SJ, Ugalde A, Zajdlewicz L, Laurie K, Dunn J, Chambers SK. Predictors of long-term distress in female partners of men diagnosed with prostate cancer. Psycho-oncology. 2018;27(3):946–54.PubMedCrossRef Hyde MK, Legg M, Occhipinti S, Lepore SJ, Ugalde A, Zajdlewicz L, Laurie K, Dunn J, Chambers SK. Predictors of long-term distress in female partners of men diagnosed with prostate cancer. Psycho-oncology. 2018;27(3):946–54.PubMedCrossRef
45.
Zurück zum Zitat Couper JW, Bloch S, Love A, Duchesne G, Macvean M, Kissane DW. The psychosocial impact of prostate cancer on patients and their partners. Med J Aust. 2006;185(8):428–32.PubMedCrossRef Couper JW, Bloch S, Love A, Duchesne G, Macvean M, Kissane DW. The psychosocial impact of prostate cancer on patients and their partners. Med J Aust. 2006;185(8):428–32.PubMedCrossRef
46.
Zurück zum Zitat Resendes LA, McCorkle R. Spousal responses to prostate cancer: an integrative review. Cancer Invest. 2006;24(2):192–8.PubMedCrossRef Resendes LA, McCorkle R. Spousal responses to prostate cancer: an integrative review. Cancer Invest. 2006;24(2):192–8.PubMedCrossRef
47.
Zurück zum Zitat Northouse LL, Mood DW, Montie JE, Sandler HM, Forman JD, Hussain M, Pienta KJ, Smith DC, Sanda MG, Kershaw T. Living with prostate cancer: patients’ and spouses’ psychosocial status and quality of life. J Clin Oncol. 2007;25(27):4171–7.PubMedCrossRef Northouse LL, Mood DW, Montie JE, Sandler HM, Forman JD, Hussain M, Pienta KJ, Smith DC, Sanda MG, Kershaw T. Living with prostate cancer: patients’ and spouses’ psychosocial status and quality of life. J Clin Oncol. 2007;25(27):4171–7.PubMedCrossRef
48.
Zurück zum Zitat van der Becqué YN, Aktan-Arslan M, van der Driel AGv, Rietjens JA, Witkamp E. Supportive interventions for family caregivers of patients with advanced cancer: a systematic review. Psycho‐Oncology. 2023;32(5):663–81.PubMedCrossRef van der Becqué YN, Aktan-Arslan M, van der Driel AGv, Rietjens JA, Witkamp E. Supportive interventions for family caregivers of patients with advanced cancer: a systematic review. Psycho‐Oncology. 2023;32(5):663–81.PubMedCrossRef
49.
Zurück zum Zitat Grīnfelde M. Face-to-face with the doctor online: phenomenological analysis of patient experience of teleconsultation. Hum Stud. 2022;45(4):673–96.PubMedPubMedCentralCrossRef Grīnfelde M. Face-to-face with the doctor online: phenomenological analysis of patient experience of teleconsultation. Hum Stud. 2022;45(4):673–96.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Bandura A. Social foundations of thought and action. Englewood Cliffs, NJ; 1986. p. 2. 1986(23–28. Bandura A. Social foundations of thought and action. Englewood Cliffs, NJ; 1986. p. 2. 1986(23–28.
51.
Zurück zum Zitat World Health Organization (WHO). Education and treatment in human sexuality: the training of health professionals. Tech Rep Ser. 1975;572. World Health Organization (WHO). Education and treatment in human sexuality: the training of health professionals. Tech Rep Ser. 1975;572.
52.
Zurück zum Zitat Guercio C, Mehta A. Predictors of Patient and Partner satisfaction following radical prostatectomy. Sex Med Rev. 2018;6(2):295–301.PubMedCrossRef Guercio C, Mehta A. Predictors of Patient and Partner satisfaction following radical prostatectomy. Sex Med Rev. 2018;6(2):295–301.PubMedCrossRef
53.
Zurück zum Zitat Namiki S, Arai Y. Health-related quality of life in men with localized prostate cancer. Int J Urol. 2010;17(2):125–38.PubMedCrossRef Namiki S, Arai Y. Health-related quality of life in men with localized prostate cancer. Int J Urol. 2010;17(2):125–38.PubMedCrossRef
54.
Zurück zum Zitat Collaço N, Rivas C, Matheson L, Nayoan J, Wagland R, Alexis O, Gavin A, Glaser A, Watson E. Prostate cancer and the impact on couples: a qualitative metasynthesis. Support Care Cancer. 2018;26(6):1703–13.PubMedCrossRef Collaço N, Rivas C, Matheson L, Nayoan J, Wagland R, Alexis O, Gavin A, Glaser A, Watson E. Prostate cancer and the impact on couples: a qualitative metasynthesis. Support Care Cancer. 2018;26(6):1703–13.PubMedCrossRef
55.
Zurück zum Zitat Mehta A, Pollack CE, Gillespie TW, Duby A, Carter C, Thelen-Perry S, Witmann D. What patients and partners want in interventions that support sexual recovery after prostate Cancer Treatment: an exploratory convergent mixed methods study. Sex Med. 2019;7(2):184–91.PubMedPubMedCentralCrossRef Mehta A, Pollack CE, Gillespie TW, Duby A, Carter C, Thelen-Perry S, Witmann D. What patients and partners want in interventions that support sexual recovery after prostate Cancer Treatment: an exploratory convergent mixed methods study. Sex Med. 2019;7(2):184–91.PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Chen M, Gong J, Cao Q, Luo X, Li J, Li Q. A literature review of the relationship between dyadic coping and dyadic outcomes in cancer couples. Eur J Oncol Nurs. 2021;54:102035.PubMedCrossRef Chen M, Gong J, Cao Q, Luo X, Li J, Li Q. A literature review of the relationship between dyadic coping and dyadic outcomes in cancer couples. Eur J Oncol Nurs. 2021;54:102035.PubMedCrossRef
57.
Zurück zum Zitat Falconier MK, Jackson JB, Hilpert P, Bodenmann G. Dyadic coping and relationship satisfaction: a meta-analysis. Clin Psychol Rev. 2015;42:28–46.PubMedCrossRef Falconier MK, Jackson JB, Hilpert P, Bodenmann G. Dyadic coping and relationship satisfaction: a meta-analysis. Clin Psychol Rev. 2015;42:28–46.PubMedCrossRef
58.
Zurück zum Zitat Galbraith ME, Arechiga A, Ramirez J, Pedro LW. Prostate cancer survivors’ and partners’ self-reports of health-related quality of life, treatment symptoms, and marital satisfaction 2.5–5.5 years after treatment. Oncol Nurs Forum. 2005;32(2):E30–41.PubMedCrossRef Galbraith ME, Arechiga A, Ramirez J, Pedro LW. Prostate cancer survivors’ and partners’ self-reports of health-related quality of life, treatment symptoms, and marital satisfaction 2.5–5.5 years after treatment. Oncol Nurs Forum. 2005;32(2):E30–41.PubMedCrossRef
59.
Zurück zum Zitat Krongrad A, Lai H, Burke MA, Goodkin K, Lai S. Marriage and mortality in prostate cancer. J Urol. 1996;156(5):1696–1670.PubMedCrossRef Krongrad A, Lai H, Burke MA, Goodkin K, Lai S. Marriage and mortality in prostate cancer. J Urol. 1996;156(5):1696–1670.PubMedCrossRef
60.
Zurück zum Zitat Walker LM, King N, Kwasny Z, Robinson JW. Intimacy after prostate cancer: a brief couples’ workshop is associated with improvements in relationship satisfaction. Psycho-oncology. 2017;26(9):1336–46.PubMedCrossRef Walker LM, King N, Kwasny Z, Robinson JW. Intimacy after prostate cancer: a brief couples’ workshop is associated with improvements in relationship satisfaction. Psycho-oncology. 2017;26(9):1336–46.PubMedCrossRef
Metadaten
Titel
The effectiveness of dyadic interventions for health outcomes of prostate cancer patients and informal caregivers: a systematic review and meta-analysis
verfasst von
Yuan Xiao
Jiao Sun
Min Liu
Haifeng Wang
Jingjing Guan
Publikationsdatum
01.12.2025
Verlag
BioMed Central
Erschienen in
BMC Nursing / Ausgabe 1/2025
Elektronische ISSN: 1472-6955
DOI
https://doi.org/10.1186/s12912-025-02769-8